

| 货号 | DB949018 |
|---|---|
| 品牌 | abinScience |
| 描述 | _x005F_x000d_
_x005F_x000d_
_x005F_x000d_
_x005F_x000d_
_x005F_x000d_
_x005F_x000d_
Bimagrumab ELISA Kit (DB949018) — Quantitative sandwich ELISA for Bimagrumab. Sample: Plasma, Serum. Range: 125 - 4, 000 ng/mL. Sensitivity: 97.28 ng/mL. _x005F_x000d_
_x005F_x000d_
_x005F_x000d_
_x005F_x000d_Highlights _x005F_x000d_
_x005F_x000d_
|
| 样本类型 | Serum, plasma, and other biological fluid samples |
| 灵敏度 | 3.73 ng/mL |
| 检测范围 | 31.25 – 1,000 ng/mL |
| 种属反应性 | Human |
| 靶标 | ACVR2A,ACVR2B |
| Accession号 | P27037,Q13705 |
| 应用 | ELISA |
| 检测方法 | Colorimetric |
| 实验类型 | Competitive |
| 回收率 | 80-120% |
| 运输 | 2-8 ℃ |
| 稳定性和存储 | When the kit was stored at the recommended temperature for 6 months, the signal intensity decreased by less than 20%. For unopened kits, if you want to prolong the storage time, please store the Standard, Detection A, Detection B and Microplate at - 20 ℃, the rest reagents should be store at 4℃. |
| 规格 | Bimagrumab _x005F_x000d_ |
| 别名 | BYM338, 1356922-05-8 |
| 背景 | Bimagrumab is a monoclonal anti-ActRIIA/IIB antibody that targets ActRIIA and ActRIIB simultaneously. Native ActRIIA and ActRIIB are both mediators of signaling from several TGFβ superfamily members such as activins, myostatin, and GDF11. Hence, pan-blockade by Bimagrumab achieves greater effect than a monoclonal antibody against either receptor alone, i.e. monotherapy with anti-ActRIIA antibody or anti-ActRIIB antibody. Bimagrumab has been explored as a therapy for sporadic inclusion body myositis, primary sarcopenia, and muscle wasting associated with chronic obstructive pulmonary disease. _x005F_x000d_ |
| Note | For Research Use Only. |

Standard Curve of Bimagrumab ELISA Kit



24小时产品查询

扫一扫关注我们

专属渠道经理